Intellectual Property and Competition in the Pharmaceutical Industry

AGCM, Conference presentations available here. 

Abuso del diritto al brevetto e abuso di posizione dominante: il caso Pfizer

G. Ghidini, G. Cavani, P. F. Piserà, qui. 

Italy's contribution to the June 2014 OECD discussions on generic pharmaceuticals and competition

Here. Other documentation on the same topic here. 

The Administrative Supreme Court Confirms AGCM's Pfizer Decision

C. D'Amore, here.

Refusal by CNMCcompetencia to open infringement proceedings against Pfizer for abuse of dominant position

Here (Spanish).

When Competition Law Analysis Goes Wrong – The Italian Pfizer/Pharmacia Case

D. Geradin, here.

Pfizer: TAR annulla il provvedimento dell'AGCM

Sentenza qui. 

Italian Pfizer Case (3)

T. Graf, here.
(1 here and 2 here)